Anavex Life Sciences Corp (AVXL)
3.82
-0.07
(-1.80%)
USD |
NASDAQ |
May 10, 16:00
3.82
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences 1 Year Total Returns (Daily): -57.11% for May 9, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 09, 2024 | -57.11% |
May 08, 2024 | -55.89% |
May 07, 2024 | -54.50% |
May 06, 2024 | -54.50% |
May 03, 2024 | -53.84% |
May 02, 2024 | -53.00% |
May 01, 2024 | -55.11% |
April 30, 2024 | -55.16% |
April 29, 2024 | -55.16% |
April 26, 2024 | -58.25% |
April 25, 2024 | -56.37% |
April 24, 2024 | -56.56% |
April 23, 2024 | -54.17% |
April 22, 2024 | -54.17% |
April 19, 2024 | -53.85% |
April 18, 2024 | -53.20% |
April 17, 2024 | -49.94% |
April 16, 2024 | -47.72% |
April 15, 2024 | -46.32% |
April 12, 2024 | -43.93% |
April 11, 2024 | -41.98% |
April 10, 2024 | -44.29% |
April 09, 2024 | -43.65% |
April 08, 2024 | -43.65% |
April 05, 2024 | -43.84% |
Date | Value |
---|---|
April 04, 2024 | -44.49% |
April 03, 2024 | -45.71% |
April 02, 2024 | -47.02% |
April 01, 2024 | -41.42% |
March 28, 2024 | -38.82% |
March 27, 2024 | -40.54% |
March 26, 2024 | -44.50% |
March 25, 2024 | -47.82% |
March 22, 2024 | -45.31% |
March 21, 2024 | -43.85% |
March 20, 2024 | -44.71% |
March 19, 2024 | -49.11% |
March 18, 2024 | -49.32% |
March 15, 2024 | -45.41% |
March 14, 2024 | -46.07% |
March 13, 2024 | -42.77% |
March 12, 2024 | -42.09% |
March 11, 2024 | -42.20% |
March 08, 2024 | -46.09% |
March 07, 2024 | -47.20% |
March 06, 2024 | -49.14% |
March 05, 2024 | -49.85% |
March 04, 2024 | -48.54% |
March 01, 2024 | -45.45% |
February 29, 2024 | -46.01% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-65.66%
Minimum
Jun 28 2022
547.8%
Maximum
Mar 16 2021
58.60%
Average
2.54%
Median
1 Year Total Returns (Daily) Benchmarks
Ventyx Biosciences Inc | -88.58% |
Checkpoint Therapeutics Inc | -43.88% |
NovaBay Pharmaceuticals Inc | -90.89% |
Palatin Technologies Inc | 5.38% |
iBio Inc | -91.38% |